IHH Healthcare - RHB Invest 2024-11-29: Charting Stronger Growth Ahead; Keep BUY

• Maintain BUY with a higher SOP-derived IHH Healthcare's target price of MYR9.10 from MYR8.80, 26% upside.
• IHH Healthcare’s 9M24 core earnings of MYR1,367.8m beat estimates, accounting for 81% and 72% of our and consensus’ expectations. The stronger-than-expected results were driven by sustained demand for healthcare services, better case-mix of more acute patients, and timely price adjustment to counter against inflation.
• - Read this at SGinvestors.io -

Results overview.

• - Read this at SGinvestors.io -
• On a sequential basis, the H&H segment grew 1% q-o-q on the back of higher patients admission volume (except for Turkey due to summer break).
• Operational beds number was largely flattish y-o-y and q-o-q, at 12,222. Its bed occupancy rate (BOR) improved 3ppt q-o-q to 73%.

Segmental breakdown.

• Read more at SGinvestors.io.

Above is an excerpt from a report by RHB Securities Research.
Clients of RHB may be the first to access the full PDF report @ https://www.rhbtradesmart.com/.

Read also RHB's most recent report:
2026-01-27 IHH Healthcare - Diversified Resilience; Maintain BUY.

Previous report by RHB:
2025-11-28 IHH Healthcare - Shifting Gears; Maintain BUY.

Price targets by other brokers at IHH Healthcare Target Prices.

Listing of research reports at IHH Healthcare Analyst Reports.

Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividend Payout Dates & Corporate Actions,
IHH Healthcare News